real doctors real people - Joshua Berkowitz
Life for Josh Berkowitz, a third year resident in Internal Medicine / Pediatrics, is constantly at full speed. If he #39;s not with a patient at the hospital, in a clinic or with his family being a husband and father, then you #39;ll find him on the field competing in Ultimate Frisbee.From:uncmedicineViews:2 0ratingsTime:02:31More inEducation
View original post here:
Dr. Judith McBean
Dr. Judith McBean is a obstetrician/gynecologist with Brattleboro Obstetrics and Gynecology (Brattleboro OBGYN) which is a member of BMH Physician Group located on the Brattleboro Memorial Hospital campus in the Gannett Building. Dr. McBean is board-certified in obstetrics, gynecology, reproductive endocrinology and infertility. She is a graduate of University of Vermont College of Medicine following which she completed her internship and residency, Medical Center Hospital, University of Vermont. http://www.bmhvt.org brattleboroobgyn.comFrom:BMHospitalViews:1 0ratingsTime:01:42More inNonprofits Activism
See the article here:
Effect of sanctions on the Iranian patients-Iran Today-11-13-2012
Thalassemia, Hemophilia, Hepatitis, Multiple Sclerosis, Diabetes, and different types of cancer are only some of the medical conditions affecting the human body which require special care. Patients suffering from these diseases usually struggle to receive the costly and ongoing medical treatment that they need. In Iran, the ordeal is even tougher. Such patients not only have to worry about keeping up with the increasing costs of their treatments but now as a result of tighter sanctions imposed by the US and the EU they also have to deal with the severe shortage of the medicine that they need. The medication these patients require is mostly produced in Europe and North America. Although the sanctions do not directly ban selling medicine and medical supplies to Iran, sanctions on the banking sector which have made banking transactions impossible are effectively hindering the import of medicine. Efforts made by the Iranian government to domestically produce these drugs have so far failed also because of raw material shortage in the pharmaceutical industry for the same reasons. In this edition of the show we will be looking into the nature of the US-led sanctions against Iran and the consequences of these sanctions on patients suffering from special medical conditions. Watch this video on our website: http://www.presstv.com Follow our Facebook on: http://www.facebook.com Follow our Twitter on: twitter.com Follow our Tumblr on: presstvchannel.tumblr.comFrom:PressTVGlobalNewsViews:1 0ratingsTime:25:55More inNews Politics
Visit link:
Effect of sanctions on the Iranian patients-Iran Today-11-13-2012 - Video
Unseen Medicine: Discovering Integrative Healing Modalities (2013) - Documentary Trailer
I received a "Special Thanks" credit for my involvement with this feature length documentary which explores various alternative medicine and healing approaches. Its director/producer, Christopher Essey, has worked on numerous projects in the industry including Boardwalk Empire, Jeremy Fink and the Meaning of Life, Goat and a film I produced called Mafia Man: Robstown Gangster.From:ronniecinemaViews:2 0ratingsTime:06:00More inFilm Animation
Read the original:
Unseen Medicine: Discovering Integrative Healing Modalities (2013) - Documentary Trailer - Video
YouAid: Doctor Stefano Barco at Mahuninga Hospital
Dr. Stefano Barco is an Italian MD from University of Pavia, specializing in Internal Medicine and Haemostasis Disease. Stefano spent three weeks in Mahuninga Health Center in September 2011 helping to improve the quality and the medical organization. He has created medical records for each patients for an appropriate management and follow-up; moreover, he organised the official medical registry of the hospital, donating also three new personal computers. Anna is a six-years-old child from Mahuninga village. In June 2011, due to a sudden fire in the village, Anna felt in the flames and reported burns on 40% of her body. Thanks to Mahuninga Health Center and its workers, she was immediately treated and saved from certain death, and now she is fine. During the three months say in the hospital as in-patient, Anna met Dr. Stefano and she was very interested in... his harmonica! follow us on: facebook.com/reteYouAid youaid.it contacts: retesolidaleyouaid@gmail.comFrom:YouAidTVViews:0 0ratingsTime:02:29More inNonprofits Activism
See original here:
YouAid: Doctor Alice Trinchero at Mahuninga Hospital
Dr. Alice Trinchero is an Italian MD from University of Pavia, specializing in Internal Medicine and Haemostasis Disease. Alice spent three weeks in Mahuninga Health Center in December 2011 working side by side with the local staff. The efforts focused on the laboratory procedures, especially for what concern the diagnosis of malaria thanks to the new stains brought from Pavia. Thanks to the materials in the hospital and the knowledge shared between Alice and the "Sisters" , it was possible to face many difficult cases, in particular some cases of cerebral malaria, and treat them with great results. follow us on: facebook.com/reteYouAid youaid.it contacts: retesolidaleyouaid@gmail.com Music: I don #39;t own rights over it - fair useFrom:YouAidTVViews:0 0ratingsTime:04:19More inNonprofits Activism
Read this article:
YouAid: Doctor Alice Trinchero at Mahuninga Hospital - Video
13 November 2012 Last updated at 20:03 ET By Michelle Roberts Health editor, BBC News online
A global treaty to crack down on the deadly trade of fake medicines is urgently needed, say experts.
Currently, there are more sanctions around the use of illegal tobacco than counterfeit drugs.
Writing in the British Medical Journal, experts urge the World Health Organization to set up a framework akin to its one tobacco control to safeguard the public.
WHO says more than one in every 10 drug products in poorer nations are fake.
A third of malaria drugs are counterfeit, research suggests.
In richer countries, medicine safety is better, but substandard and falsified drugs still cause thousands of adverse reactions and some deaths.
Recently, in the US, contaminated drug supplies caused an outbreak of meningitis that has so far killed 16 people.
Amir Attaran and colleagues from the World Federation of Public Health Associations, International Pharmaceutical Federation and the International Council of Nurses, say while governments and drug companies alike deplore unsafe medicines, it is difficult to achieve agreement on action because discussions too often trespass into conflict-prone areas such as pharmaceutical pricing or intellectual property rights.
In Canada we have seen a fake version of the heart drug Avastin come into the country that contains no active drug, just starch and nail polish remover
Go here to read the rest:
NASHVILLE, Tenn.--(BUSINESS WIRE)--
Healthways (HWAY) today announced a five-year extension of their decade-long agreement with Johns Hopkins Medicine (JHM) to leverage its clinical, research and educational capabilities in the rapid development, testing and distribution of new well-being improvement science and solutions. Johns Hopkins HealthCare Solutions (JHHCS), a division of Johns Hopkins HealthCare, will coordinate support of the joint effort by faculty and staff members of the institution.
As a leading provider of health and medical services to the population we serve and as a major employer, Johns Hopkins Medicine faces many of the same challenges confronting healthcare organizations worldwide, said JHHC President Patricia M. C. Brown, JD. Successfully meeting these challenges requires new solutions, new distribution and payment models, and new partnerships.
Our new agreement with Johns Hopkins reflects a major change in focus for our ongoing collaboration, noted Ben R. Leedle, Jr., Healthways president and CEO. Historically, we sought Hopkins support to validate our clinical pathways, validate our outcomes and provide support and guidance to our physician outreach efforts. As our relationship matured over the past decade, however, we came to recognize even greater opportunities that could be pursued by harnessing our unique capabilities to contribute to practical research into new approaches that would accelerate our respective abilities to address the health needs of each individual in the populations we serve, rather than just the care needs of those who are already sick.
The new agreement with JHM reflects Healthways' long-term commitment to developing and distributing programs based on sound clinical research, such as the joint market introduction of InnergyTM, the commercial version of the new standard of care weight-loss program validated by faculty of the Johns Hopkins University School of Medicine in the NIH-supported POWER1 trial concluded last year.
We have successfully tested this new model for collaboration through our participation in the POWER trial and the market introduction of Innergy, Leedle said. We now look forward with confidence to the development and distribution of new, even more effective models to engage individuals of all ages in the lifestyle and health behaviors that we know will contribute to their improved well-being, reduced health-related cost and improved performance.
The research, program development and distribution activities contemplated by the new agreement will be guided by a Joint Steering Committee (JSC) that includes clinical, research, program development and distribution experts from both JHM, JHHCS and Healthways. Chaired by Frederick L Brancati, MD, MHS, chair of the Division of General Internal Medicine at the Johns Hopkins University School of Medicine and the executive medical director of JHHCS, the Joint Steering Committee will set the agenda for, and guide, the workflows contemplated under the agreement. In addition, the JHHCS members of the JSC will provide ongoing oversight of all services provided to Healthways by JHM and its affiliates, and their respective faculty and staff, in support of the organizations mutual objectives.
It is increasingly clear that the role of health care professionals and institutions will be undergoing significant change in the face of burgeoning epidemics of lifestyle-dependent diseases and their contribution to unsustainable levels of cost both in the U.S. and overseas, Brancati said. The purpose of this agreement is to harness the unique capabilities of both organizations to accelerate the development and distribution of new solutions to effectively address those challenges.
About Healthways
Healthways is the largest independent global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the Company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities. We provide highly specific and personalized support for each individual and their team of experts to optimize each participants health and productivity and to reduce health-related costs. Results are achieved by addressing longitudinal health risks and care needs of everyone in a given population. The Company has scaled its proprietary technology infrastructure and delivery capabilities developed over 30 years and now serves approximately 40 million people on four continents. Learn more at http://www.healthways.com.
Read more:
DALLAS and JACKSONVILLE, Fla., Nov. 14, 2012 /PRNewswire/ -- U.S. Preventive Medicine, Inc. (USPM) has announced plans to open a joint venture in Singapore to launch its global health movement in the Asian market. This new venture, Asia Preventive Medicine, is in tandem with USPM's global efforts in the United States, United Kingdom, United Arab Emirates and soon in India.
"Our global strategy is to take our clinically focused preventive medicine program known as The Prevention Plan, as well as our Macaw mobile application, worldwide," said Christopher Fey, USPM Chairman and CEO. "Singapore gives us the hub to launch into Asia and have the opportunity to offer more good years to several billion people."
USPM's expansion is directly in line with the company's mission to make the world a healthier place. Currently, Macaw, the health and fitness mobile app from USPM, has members in more than 20 countries, and USPM's Prevention Plan has members in all 50 states, Canada, Great Britain and the United Arab Emirates. The company's new joint venture in Singapore will allow USPM to reach a large population and provide clinically proven, technology-based solutions to help people take control of their health.
Dr. Ron Loeppke, M.D., FACPM, USPM Vice Chairman states, "The impact from the 'Silent Epidemics' of chronic illness (e.g. Obesity, Diabetes, Heart Disease, Cancer) is a critical global risk that is destructive and debilitating to individuals as well as nations. We and others have proven that wellness works and prevention pays. Our mission is to leverage the power of prevention to help make the world a healthier place."
About U.S. Preventive Medicine
U.S. Preventive Medicine (www.USPM.com) is a leading, cloud-based global preventive health movement focused on saving lives and money by keeping people healthy and better managing chronic conditions before they progress. Innovative products -- The Prevention Plan(TM) web-based health management platform and Macaw mobile health & fitness app -- are based on the clinical science of preventive medicine: primary (wellness and health promotion to keep healthy people healthy), secondary (screening for earlier detection/diagnosis) and tertiary (early evidence-based treatment to reduce complications and disability). The company is accredited in wellness and health promotion by NCQA (the National Committee for Quality Assurance) and disease management by URAC. More information can be found on Facebook (Facebook.com/ThePreventionPlan( http://www.facebook.com/ThePreventionPlan )), Twitter (@USPM( http://twitter.com/USPM )) and YouTube (YouTube.com/thepreventionchannel( http://www.youtube.com/thepreventionchannel )). Macaw is available for free download on iPhone and Android smartphones at http://www.MacawApp.com.
About The Prevention Plan
The Prevention Plan is a clinically proven, step-by-step health management program designed to help people take control of their health. Through a health appraisal and comprehensive blood test panel, The Plan identifies an individual's top health risks and designs a customized plan of action to reduce those risks. Each member is supported by health coaching, robust online tools, plan-wide challenges with rewards, and a dynamic Prevention ScoreSM to help them stay motivated and on track to improving their health. A study published in the peer-reviewed journal Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction," (October 2010) demonstrated that The Prevention Plan is effective in achieving measurable improvements in key health risk factors after just one year on the plan. Recent findings show that after two years on The Prevention Plan, members significantly reduced health risks in 14 of 15 key risk areas.
About Macaw
Unlike other available health and fitness apps, Macaw is based on the clinical science of preventive medicine and is universally designed for people who exercise regularly as well as those who are novices when it comes to physical activity. Macaw transforms a smartphone into the ultimate personal health monitor, connecting an individual's health apps and wireless devices for tracking weight, fitness, overall activity and biometrics -- including pedometers, glucose meters, activity armbands, scales, labs, sleep managers, mobile weight loss apps and blood pressure cuffs -- into a single app for complete tracking. Macaw users are able to track their physical activity, nutrition, progress and health knowledge while engaging in games that unlock prizes.
Visit link:
U.S. Preventive Medicine To Open Singapore Operations Center To Launch Asia Preventive Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Foundation Medicine, Inc. and ARIAD Pharmaceuticals, Inc. (ARIA) today announced a genomic profiling collaboration to study AP26113, ARIADs investigational dual-inhibitor of ALK and EGFR in patients with non-small cell lung cancer (NSCLC) and other cancers. Foundation Medicine will work with ARIAD to generate genomic profile information for patients enrolled in ARIADs ongoing Phase 1/2 trial and these data will be matched with clinical observations to understand the activity and selectivity profile of AP26113.
It is important that we have a deep molecular understanding of patients tumors as they begin treatment with AP26113, especially those patients with complex prior treatment histories, stated Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer at ARIAD. Foundation Medicine is at the forefront of genomic profiling technologies that will provide molecular insights on a wide array of clinically relevant tumor genes including ALK and EGFR alteration status. We look forward to collaborating on the AP26113 program as we move into anticipated pivotal trial(s) in 2013.
This study is an example of how cancer complexity often defies single-marker analysis in drug development, said Michael Pellini, M.D., president and chief executive officer, Foundation Medicine. We expect that our comprehensive genomic profile will help to identify the optimal patient population for AP26113 and may potentially enable an expedited development timeline.
About ARIAD
ARIAD Pharmaceuticals, Inc.is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIADs approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.comor follow ARIAD onTwitter.
About Foundation Medicine
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patients unique cancer. The companys initial clinical product, FoundationOne, is a fully informative genomic profile to identify a patients individual molecular alterations and match them with relevant targeted therapies and clinical trials. Foundation Medicines molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.foundationmedicine.com.
Foundation Medicine is a registered trademark, and FoundationOne is a trademark, of Foundation Medicine, Inc.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121113005372/en/
Go here to read the rest:
WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business update.
Total revenue increased to $0.6 million in the third quarter of 2012 compared to $0.2 million in the same period in 2011. Product revenue from the BGM Galectin-3(R) test was $0.6 million in the third quarter of 2012, compared to $0.1 million in the same period in 2011.
Operating expenses for the third quarter of 2012 increased by $2.1 million to $7.2 million compared to 2011. This increase was driven by an increase in research and development investment of $0.6 million related primarily to the CardioSCORE(TM) test program and by an increase in sales and marketing expense of $0.9 million to support commercialization of the BGM Galectin-3 test. General and administrative expenses increased $0.4 million primarily due to personnel related costs and public company related expenses.
Net loss for the quarter was $6.8 million compared with a loss of $4.9 million in the third quarter of 2011.
Basic and diluted net loss per share attributable to common shareholders was $(0.34) in the third quarter of 2012, compared with basic and diluted net income per share of $(0.25) for the same period of 2011.
At September 30, 2012, the Company had cash and cash equivalents totaling approximately $18.1 million compared to $24.4 million at December 31, 2011.
"Over the past quarter, we continued to make important progress with the BGM Galectin-3 test by augmenting U.S. sales and marketing efforts and expanding into other markets," said Eric Bouvier, president and chief executive officer of BG Medicine. "With our new corporate strategy and structure in place, we look forward to maximizing control over the commercial execution of the BGM Galectin-3 and CardioSCORE tests, which we believe will assist us to become a leader in delivering novel cardiovascular diagnostics that address significant unmet medical needs."
Financial Results for the Nine Months Ended September 30, 2012
Total revenue for the nine months ended September 30, 2012 was $1.7 million compared to $1.3 million in the same period in 2011. Product revenue from the BGM Galectin-3 test was $1.6 million in the nine months ended September 2012, compared to $0.1 million in the same period in 2011. Service revenue from collaborations decreased to $0.2 million in the nine months ended September 30, 2012 from $1.1 million in the corresponding period in 2011 as the Company focused its efforts on the commercialization of the BGM Galectin-3 test.
Operating expenses for the first nine months of 2012 were $21.9 million compared with operating expenses for the comparable period in 2011 of $14.0 million. This increase in operating expenses included higher research and development investments of $1.7 million primarily related to the BGM Galectin-3 and CardioSCORE test programs and an increase in sales and marketing expenses of $3.7 million related primarily to commercialization of the BGM Galectin-3 test in the U.S. and European markets. General and administrative expenses increased $2.2 million, mainly from personnel related costs and public company related expenses.
Originally posted here:
BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update
WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an update on its new commercial strategy to speed the adoption of its cardiovascular diagnostic tests -- the BGM Galectin-3(R) test and the CardioSCORETM test.
Under the plan announced today, BG Medicine has begun to build its own dedicated sales organization and has taken steps to open its own CLIA lab in order to play a more active role alongside its commercial partners in driving sales and marketing efforts. In addition, the company highlighted its new Galectin-3 promotion effort, and provided an update on the regulatory and commercial path forward for CardioSCORE.
"We have taken a series of important steps over the past year to realign BG Medicine into a more commercially-focused company, capable of playing a larger role in facilitating the market adoption of our innovative cardiovascular diagnostic tests," said Eric Bouvier, President and CEO of BG Medicine. "The steps outlined today represent the culmination of our efforts to transform BG Medicine. Taken together, these actions place us in a much stronger position to control our own destiny and drive our own commercial success."
Highlights of the new commercial strategy include:
In addition, the company announced a strategic reorganization in its research and development department, away from its previous focus on early stage discovery and toward a more commercially-oriented role in support of the BGM Galectin-3 and CardioSCORE tests in the marketplace. As a result of this reorganization, 11 positions in early discovery research have been eliminated, enabling the company to dedicate a greater share of its R&D budget to commercial support and market growth activities.
"The implementation of the aggressive new strategy announced today will be a critical driver in our ongoing transformation into a full-scale commercial organization," continued Mr. Bouvier. "This is an important time in the evolution of BG Medicine and we look forward to sharing our progress in our execution of this strategy with our shareholders."
About BG Medicine, Inc.
BG Medicine, Inc. (BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company's first commercialized product, the BGM Galectin-3(R) test for use in patients with chronic heart failure, is available in the United States and Europe. BG Medicine is also developing the CardioSCORETM test, a blood test designed to aid in the assessment of an individual's risk for near-term major cardiovascular events. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.
The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352
Special Note Regarding Forward-looking Statements
See the original post here:
#39;21 and Over #39; Trailer HD
http://www.hollywood.com #39;21 and Over #39; Trailer HD Directors Jon Lucas, Scott Moore Starring: Miles Teller, Justin Chon and Jonathan Keltz The night before his big medical school exam, a promising student celebrates his 21st birthday with his two best friends. For more movie trailers, celebrity interviews and box office news visit Hollywood.com!From:hollywoodstreamsViews:18074 549ratingsTime:02:41More inFilm Animation
Originally posted here:
Dr. Mark Torchia, an Elsevier Author, at EB 2012
Dr. Torchia discusses the importance on the need for greater focus on student comprehension in the growing trend of e-learning in medical school. He also explains how this is applied to his latest books, "Before We Are Born, 8th Edition" and "The Developing Human, 9th Edition." Finally, Dr. Torchia shares some simple advice for med students - "Enjoy yourself." For more information on the titles discussed, please visit the following links: "Before We Are Born, 8th Edition" - http://www.us.elsevierhealth.com "The Developing Human, 9th Edition" - http://www.us.elsevierhealth.com To learn more about Dr. Torchia, please visit his official Elsevier Authors page at elsevierauthors.comFrom:elsevierauthorsViews:1 0ratingsTime:04:33More inScience Technology
Read more here:
21 and Over 2012 Full Movie Part 1/9
watch the full movie online at tinyurl.com Studio: Relativity Media Director: Jon Lucas, Scott Moore Screenwriter: Jon Lucas, Scott Moore Starring: Miles Teller, Justin Chon, Skylar Astin, Sarah Wright, Franois Chau, Jonathan Keltz, Daniel Booko, Dustin Ybarra Genre: Comedy Plot Summary: Skylar Astin ("Pitch Perfect"), Miles Teller ("Footloose") and Justin Chon ("Twilight") star in "21 and Over," a hilarious movie that showcases a rite of passage gone horribly wrong. Straight-A college student Jeff Chang has always done what #39;s expected of him. But when his two best friends Casey and Miller surprise him with a visit for his 21st birthday, he decides to do the unexpected for a change, even though his critical medical school interview is early the next morning. What was supposed to be one beer becomes one night of chaos, over indulgence and utter debauchery in this outrageous comedy. Miles Teller, Justin Chon, Skylar Astin, Sarah Wright,21 and over, uncut, Free, movie, Film, Full, Complete, Leaked, Part 1, Part 2, Part, Stream, Hd, Trailer, Exclusive, Scenes, Download, 2012, Watch Online, Red Band, watch, stream, Where can I see, Releases, Showtimes, videoFrom:ClimpenelaValitiaViews:0 0ratingsTime:10:36More inFilm Animation
Originally posted here:
21 AND OVER Trailer
The night before his big medical school exam, a promising student celebrates his 21st birthday with his two best friends.From:OfficialTrailer9Views:0 0ratingsTime:02:39More inFilm Animation
Read more here:
Greys Anatomy Season 8 Episode 8 - Heart-Shaped Box
http://www.greysanatomyseries.com The doctors become nostalgic when George O #39;Malley #39;s mother, Louise, returns to Seattle Grace for medical help after a botched surgery at a neighboring hospital; the residents are inspired by a medical miracle when they witness a harvested heart that continues to beat outside the body; a new pediatric fellow excites Arizona and makes Alex feel threatened; Jackson lets his suspicions about Mark and Lexie interfere with his work; and Henry and Teddy have their first marital fight when he expresses interest in pursuing medical school. Greys Anatomy s08e08 Greys Anatomy S8e8 s08e8 S8e8 8x8 Season 8 episode 8 tv shows S8 s08 se8 e8 ep8 8x8 4 S08 E8 HQ episodes serie series watch online complete full tv television hd hq part 1 part 2 part 3 part 4. Watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box full free watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box full episode watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box free online watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box for free watch full Greys Anatomy Season 8 Episode 8 Heart-Shaped Box watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box full episode online watch Greys Anatomy Season 8 Episode 8 Heart-Shaped Box watch online.From:Emma AllenViews:0 0ratingsTime:08:33More inPeople Blogs
View post:
21 and Over 2012 Full Scenes
watch the full movie at redir.ec Studio: Relativity Media Director: Jon Lucas, Scott Moore Screenwriter: Jon Lucas, Scott Moore Starring: Miles Teller, Justin Chon, Skylar Astin, Sarah Wright, Franois Chau, Jonathan Keltz, Daniel Booko, Dustin Ybarra Genre: Comedy Plot Summary: Skylar Astin ("Pitch Perfect"), Miles Teller ("Footloose") and Justin Chon ("Twilight") star in "21 and Over," a hilarious movie that showcases a rite of passage gone horribly wrong. Straight-A college student Jeff Chang has always done what #39;s expected of him. But when his two best friends Casey and Miller surprise him with a visit for his 21st birthday, he decides to do the unexpected for a change, even though his critical medical school interview is early the next morning. What was supposed to be one beer becomes one night of chaos, over indulgence and utter debauchery in this outrageous comedy. Miles Teller, Justin Chon, Skylar Astin, Sarah Wright,21 and over, uncut, Free, movie, Film, Full, Complete, Leaked, Part 1, Part 2, Part, Stream, Hd, Trailer, Exclusive, Scenes, Download, 2012, Watch Online, Red Band, watch, stream, Where can I see, Releases, Showtimes, videoFrom:melocvanajivadoraViews:0 0ratingsTime:10:01More inFilm Animation
View post:
Nursing School or Medical School?
It #39;s the age old question for any student considering a career in healthcare: Nursing school or medical school? http://www.registerednursern.comFrom:RegisteredNurseRNViews:1 0ratingsTime:07:23More inEducation
Here is the original post:
Premiere Medical
Get a great deal here redirect.viglink.com?key=1f0527e04637dcdb26bf99b11836bfbf out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB008F83V3M Product Description Premiere Medical As the medical school environment has evolved, so has the need for a good quality student microscope. Premiere Microscopes and Gorilla Scientific have teamed up to introduce the Elevation Medical Student Microscope Series. These are the perfect microscopes for medical students. These binocular microscopes incorporate all the best features of a high-quality laboratory microscope but at an economical price.HighlightHigh quality achromatic 4X, 10X, 40X, 100X objectives are available for our MSMJ3 or you can upgrade to the MSM01 for our ultra flat images with PLAN 4X, 10X, 40X and 100X objectivesVariable control, cool Illumination provided by low energy bright LED bulbs that can be adjusted for various light intensities. Rechargeable battery to take this microscope out in the fieldErgonomic mechanical stageLow position coaxial course and fine focusPerfect size for most lockersFREE carrying case. No more buying an expensive microscope only to watch it get dented and dinged as you move it from location to location. This padded carrying case has Velcro straps to secure your microscope. Easy to hold handles lets you carry your microscope without fear of damageBundle comes with the following additional items AC adapter, vinyl dust cover, spare fuse, Carrying Case, 2 Rubber eyeguards, 2 10X eyepieces 20X ...From:erlinda longoViews:0 0ratingsTime:00:52More inScience Technology
See the article here: